Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CHEK
stocks logo

CHEK

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Financial AI Agent
Financial AI Agent

Valuation Metrics

The current forward P/E ratio for Check Cap Ltd (CHEK.O) is 0.00, compared to its 5-year average forward P/E of -3.12. For a more detailed relative valuation and DCF analysis to assess Check Cap Ltd 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-3.12
Current PE
0.00
Overvalued PE
-0.66
Undervalued PE
-5.57

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.02
Overvalued PS
0.01
Undervalued PS
-0.00
Intellectia AI SwingMax
Intellectia AI SwingMax

Financials

Annual
Quarterly
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

CHEK News & Events

Events Timeline

(ET)
2025-09-12
17:46:33
Check-Cap and MBody AI Reach Merger Agreement
select
2025-06-04 (ET)
2025-06-04
07:07:22
Check-Cap 'publicly condemned' MediPharm Labs, Chairman Chris Taves
select
2025-05-23 (ET)
2025-05-23
13:04:17
Medipharm Labs provides information on three Apollo Capital nominees
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
2.0
09-16TipRanks
3 Penny Stocks to Keep an Eye on This Week, 9/16/25

  • Penny Stocks to Watch: AtlasClear Holdings, Check-Cap Ltd., and aTyr Pharma are highlighted as top penny stocks to monitor on September 16, 2025, based on their high Dollar Volume and significant stock price movements.

  • AtlasClear Holdings (ATCH): The company experienced a 153% stock price increase and a Dollar Volume of $493.14 million after reporting a substantial rise in net income and introducing a new broker-dealer.

  • Check-Cap Ltd. (CHEK): CHEK's stock surged by 184% with a Dollar Volume of $274.77 million following the announcement of a merger with AI company MBody AI, pending shareholder approval.

  • aTyr Pharma (ATYR): Despite a significant drop of over 83% in stock price and a Dollar Volume of $157.38 million, aTyr Pharma plans to discuss its Phase 3 clinical trial results with the FDA, believing in the potential of its treatment for pulmonary sarcoidosis.

[object Object]
Preview
4.5
09-16Benzinga
Crude Oil Increases by 1%; New York's Manufacturing Activity Declines in September

  • U.S. Stock Market Performance: U.S. stocks saw gains with the Dow Jones up 0.1%, NASDAQ rising 0.75%, and S&P 500 increasing by 0.37%. Consumer discretionary shares led the rise, while health care stocks fell by 0.5%.

  • Significant Stock Movements: Check-Cap Ltd. shares surged 261% following a merger announcement, while Helius Medical Technologies saw a 161% increase after launching a treasury strategy. Conversely, aTyr Pharma's shares plummeted 81% due to disappointing study results.

  • Commodity Prices: Oil prices increased by 1% to $63.31, while gold rose 0.3%. Silver saw a slight decline of 0.1%, and copper prices increased by 1%.

  • International Market Trends: European shares mostly rose, with the eurozone's STOXX 600 up 0.47%. Asian markets were mixed, with Hong Kong's Hang Seng gaining slightly, while China's Shanghai Composite and India's BSE Sensex experienced minor declines.

[object Object]
Preview
4.5
09-15Benzinga
Nasdaq Rises by More Than 100 Points; Tesla Stock Soars

  • U.S. Stock Market Performance: U.S. stocks opened higher, with the Nasdaq Composite gaining over 100 points, while the Dow and S&P 500 also saw increases of 0.19% and 0.47%, respectively. Communication services stocks rose by 1.7%, but consumer staples fell by 0.6%.

  • Tesla's Share Purchase: Tesla shares rose approximately 6% after CEO Elon Musk purchased 2.57 million shares, increasing his indirect ownership to about 413 million shares.

  • Notable Stock Movements: Check-Cap Ltd. shares surged 233% following a merger announcement, while Helius Medical Technologies saw a 179% increase after launching a treasury strategy. Conversely, aTyr Pharma's shares plummeted 82% after disappointing clinical trial results.

  • Global Market Trends: European shares rose, with the eurozone's STOXX 600 up 0.6%, while Asian markets were mixed. The New York Empire State Manufacturing Index fell to -8.7 in September, indicating a decline in manufacturing activity.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Check Cap Ltd (CHEK) stock price today?

The current price of CHEK is 1.62 USD — it has increased 1.86 % in the last trading day.

arrow icon

What is Check Cap Ltd (CHEK)'s business?

Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.

arrow icon

What is the price predicton of CHEK Stock?

Wall Street analysts forecast CHEK stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CHEK is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Check Cap Ltd (CHEK)'s revenue for the last quarter?

Check Cap Ltd revenue for the last quarter amounts to -4.09M USD, decreased -3.08 % YoY.

arrow icon

What is Check Cap Ltd (CHEK)'s earnings per share (EPS) for the last quarter?

Check Cap Ltd. EPS for the last quarter amounts to -3539000.00 USD, decreased -16.49 % YoY.

arrow icon

What changes have occurred in the market's expectations for Check Cap Ltd (CHEK)'s fundamentals?

The market is revising No Change the revenue expectations for CHEK for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by 140.30%.
arrow icon

How many employees does Check Cap Ltd (CHEK). have?

Check Cap Ltd (CHEK) has 85 emplpoyees as of December 05 2025.

arrow icon

What is Check Cap Ltd (CHEK) market cap?

Today CHEK has the market capitalization of 11.46M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free